Zevra Therapeutics said it was nominated for the 2026 Prix Galien USA Awards in the Best Product for Rare/Orphan Diseases category. The nomination marks a high-

BWB News TV • 2026-08-12 19:26 UTC • By Billy Odell Tucker-Robinson

Zevra Therapeutics said it was nominated for the 2026 Prix Galien USA Awards in the Best Product for Rare/Orphan Diseases category. The nomination marks a high-profile industry endorsement as the clinical-stage biotech advances therapies for rare diseases.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly